Secure Your Nasodine® Today TopQuality Nasal Spray

Nasodine Nasal Spray Australia. Firebrick’s nasal hygiene spray launched in the US without FDA approvals The Sentiment A new treatment, called Nasodine, has been developed by Australian pharmaceutical firm Firebrick co-founder Dr Peter Molloy. "Nasodine is a first-in-class nasal spray medicine that actually targets the viral cause of the common cold, where colds start - in the nose." The primary endpoint of the trial will be the impact of Nasodine treatment (3 sprays per nostril, 4 times daily for 5 days) on overall cold severity in the viral-infected population.

You could soon be able to use a nasal spray to kill off the common cold A new treatment, called Nasodine, has been developed by Australian pharmaceutical firm Firebrick co-founder Dr Peter Molloy.

Secure Your Nasodine® Today TopQuality Nasal Spray

A study at the Basil Hetzel Institute in Adelaide Australia showed that using a sensitive human nasal tissue model, the nasal formulation was safe for nasal use, even with long term (30 minutes) exposure. Firebrick said that the withdrawal was due to "the significant distraction and legal costs associated with proceeding," especially since the company. Nasodine® is antiseptic nasal spray designed to reach into the nasal passage to kill germs.

Nasodine® Revolutionary Nasal Spray for Daily Hygiene. A new treatment, called Nasodine, has been developed by Australian pharmaceutical firm Firebrick co-founder Dr Peter Molloy. A study at the Basil Hetzel Institute in Adelaide Australia showed that using a sensitive human nasal tissue model, the nasal formulation was safe for nasal use, even with long term (30 minutes) exposure.

Nasodine® Nasal Spray. Nasodine® is antiseptic nasal spray designed to reach into the nasal passage to kill germs. Discover Nasodine®, the best nasal cleanser for daily use to remove airborne contaminants that could disrupt nasal hygiene